GlaxoSmithKline Intellectual Property Development Limited
发明人:
Denis, Alexis,Mirguet, Olivier,Toum, Jerome
申请号：
AU2015252184
公开号：
AU2015252184A1
申请日:
2015.04.27
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to the compound (2R,2'R)-bis(((((tetrahydro-2H-pyran- 4-yl)oxy)carbonyl)oxy)methyl) 1,1'-adipoylbis(pyrrolidine-2-carboxylate), pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion of serum amyloid P component (SAP) would be beneficial, including amyloidosis, Alzheimer's disease, type 2 diabetes mellitus and osteoarthritis.
